Alm CE, Karlsten A, Madsen JE, Nordsletten L, Brattgjerd JE, Pripp AH, Frihagen F, Röhrl SM (2024)
No benefit of the trochanteric stabilizing plate on loss of fracture reduction in AO/OTA 31-A2 trochanteric fractures
Bone Jt Open, 5 (1), 37-45
DOI 10.1302/2633-1462.51.BJO-2023-0082.R1, PubMed 38240179

Andresen NK, Røssevold AH, Quaghebeur C, Gilje B, Boge B, Gombos A, Falk RS, Mathiesen RR, Julsrud L, Garred Ø, Russnes HG, Lereim RR, Chauhan SK, Lingjærde OC, Dunn C, Naume B, Kyte JA (2024)
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial
J Immunother Cancer, 12 (1)
DOI 10.1136/jitc-2023-007990, PubMed 38242720

Barnoiu OS, Johannesen TB, Diep LM, Pedersen ES, Hjelle KM, Beisland C (2024)
Prediction of clinically significant recurrence after partial nephrectomy. Data from the Cancer Registry of Norway with more than five years of follow-up
Scand J Urol, 59, 1-9
DOI 10.2340/sju.v59.18674, PubMed 38226773